Justin Hall is CEO & President at NovaBay Pharmaceuticals, Inc. (NBY). They have made 3 open-market trades across 1 company since 2019, most recently 2022-09-14.
CIK 0001663021
2 open-market purchases totalling $31K since 2021, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NBY | 83,172 | $162K |
Shares reported on the most recent Form 4, priced at the 2022-09-16 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.